Microrna marker combination for diagnosing gastric cancer and diagnostic kit

PH12021552764B1Active Publication Date: 2026-11-06MIRXES LAB PTE LTD
0 Cites 0 Cited by

Patent Information

Application Number
PH12021552764
Authority / Receiving Office
PH · PH
Patent Type
Patents
Current Assignee / Owner
Filing Date
2021-10-29
Publication Date
2026-11-06
Estimated Expiration
2041-10-29
Patent Text Reader

Abstract

The present invention relates to the field of molecular biology. Disclosed are a microRNA marker combination for diagnosing gastric cancer and a diagnostic kit. The microRNA marker combination for diagnosing gastric cancer includes at least four markers selected from: hsa-miR-29c-3p, hsa-miR-424-5p,hsa-miR-103a-3p, hsa-miR-93-5p, hsa-miR-181a-5p, hsa-miR-21-5p, hsa-miR-140-5p, hsa-miR-30e5p, hsa-miR-142-5p, hsa-miR-126-3p, hsa-miR-183-5p and hsa-miR-340-5p. The marker combination for diagnosing gastric cancer can be used to distinguish blood serum of a patient with gastric cancer from that of a healthy person. The diagnostic kit of the present invention can diagnose gastric cancers easily, effectively and noninvasively.
Need to check novelty before this filing date? Find Prior Art